{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:00:24Z","timestamp":1777561224919,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biosafety and Health"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bsheal.2024.04.004","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T09:26:36Z","timestamp":1714469196000},"page":"165-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of ursodeoxycholic acid therapy in autoimmune liver disease patients with COVID-19 and its clinical prognosis"],"prefix":"10.1016","volume":"6","author":[{"given":"Minghui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihua","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanjiao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxiao","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leiping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6082-1180","authenticated-orcid":false,"given":"Yuyong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4108-7037","authenticated-orcid":false,"given":"Yao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bsheal.2024.04.004_b0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1385\/CRIAI:18:2:127","article-title":"Autoimmunity in liver diseases","volume":"18","author":"Strassburg","year":"2000","journal-title":"Clin Rev. Allergy. Immunol."},{"key":"10.1016\/j.bsheal.2024.04.004_b0010","doi-asserted-by":"crossref","unstructured":"C.P. Strassburg, Autoimmune liver diseases and their overlap syndromes, Prax. (Bern 1994). 95 (2006) 1363-1381, https:\/\/doi.org\/10.1024\/1661-8157.95.36.1363.","DOI":"10.1024\/1661-8157.95.36.1363"},{"key":"10.1016\/j.bsheal.2024.04.004_b0015","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatol."},{"key":"10.1016\/j.bsheal.2024.04.004_b0020","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","article-title":"Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid","volume":"136","author":"Kuiper","year":"2009","journal-title":"Gastroenterol."},{"issue":"2019","key":"10.1016\/j.bsheal.2024.04.004_b0025","first-page":"394","article-title":"Primary biliary cholangitis: practice guidance from the American Association for the study of liver diseases","volume":"69","author":"Lindor","year":"2018","journal-title":"Hepatol."},{"key":"10.1016\/j.bsheal.2024.04.004_b0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bsheal.2024.04.004_b0035","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.bsheal.2024.04.004_b0040","doi-asserted-by":"crossref","unstructured":"X. Chai, L. Hu, Y. Zhang, et al., Specific ACE2 expression in cholangiocytes may cause liver damage after 2019\u2010nCoV infection [Preprint], bioRxiv (2020), https:\/\/doi.org\/10.1101\/2020.02.03.931766.","DOI":"10.1101\/2020.02.03.931766"},{"key":"10.1016\/j.bsheal.2024.04.004_b0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","article-title":"Cholangiocyte pathobiology","volume":"16","author":"Banales","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bsheal.2024.04.004_b0050","unstructured":"Surveillance Epidemiology of Coronavirus (COVID-19) Under Research Exclusion (SECURE)-CIRRHOSIS Registry, Updates and Data. https:\/\/covidcirrhosis.web.unc.edu\/updates-and-data\/, 2021 (accessed 7 April 2024)."},{"key":"10.1016\/j.bsheal.2024.04.004_b0055","unstructured":"COVID-19 in Patients with Liver Disease or Transplantation (COVID-Hep) Registry. https:\/\/www.covid-hep.net\/img\/update_20200825.pdf, 2021 (accessed 15 April 2024)."},{"key":"10.1016\/j.bsheal.2024.04.004_b0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41586-022-05594-0","article-title":"FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2","volume":"615","author":"Brevini","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bsheal.2024.04.004_b0065","unstructured":"COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). https:\/\/coronavirus.jhu.edu\/map.html, 2021 (accessed 17 April 2024)."},{"key":"10.1016\/j.bsheal.2024.04.004_b0070","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jhep.2020.08.035","article-title":"Health status of patients with autoimmune hepatitis is not affected by the SARS-CoV-2 outbreak in Flanders, Belgium","volume":"74","author":"Verhelst","year":"2021","journal-title":"J. Hepatol."},{"issue":"2020","key":"10.1016\/j.bsheal.2024.04.004_b0075","first-page":"1257","article-title":"Coronavirus disease 2019 in autoimmune hepatitis: a lesson from immunosuppressed patients","volume":"4","author":"Gerussi","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.bsheal.2024.04.004_b0080","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2020.05.008","article-title":"Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy","volume":"73","author":"Di Giorgio","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bsheal.2024.04.004_b0085","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2020.04.002","article-title":"Management of patients with autoimmune liver disease during COVID-19 pandemic","volume":"73","author":"Lleo","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bsheal.2024.04.004_b0090","doi-asserted-by":"crossref","unstructured":"Z. Wang, F. Cheng, Y. Xu, X. Li, S. Meng,Role of innate immunity in SARS-CoV-2 infection, Biosaf. Health 5 (2023) 280\u2013288, https:\/\/doi.org\/10.1016\/j.bsheal.2023.08.005.","DOI":"10.1016\/j.bsheal.2023.08.005"},{"key":"10.1016\/j.bsheal.2024.04.004_b0095","doi-asserted-by":"crossref","unstructured":"Y. Li, J. Lan, G. Wong,Advances in treatment strategies for COVID-19: Insights from other coronavirus diseases and prospects, Biosaf. Health 5 (2023) 272\u2013279, https:\/\/doi.org\/10.1016\/j.bsheal.2023.08.003.","DOI":"10.1016\/j.bsheal.2023.08.003"},{"key":"10.1016\/j.bsheal.2024.04.004_b0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2006.04.007","article-title":"Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre","volume":"45","author":"Al-Chalabi","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bsheal.2024.04.004_b0105","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.21074","article-title":"Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly","volume":"43","author":"Czaja","year":"2006","journal-title":"Hepatol."},{"key":"10.1016\/j.bsheal.2024.04.004_b0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatol."},{"key":"10.1016\/j.bsheal.2024.04.004_b0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.21229","article-title":"Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis","volume":"44","author":"Poupon","year":"2006","journal-title":"Hepatol."},{"key":"10.1016\/j.bsheal.2024.04.004_b0120","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cgh.2013.09.021","article-title":"Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis","volume":"12","author":"Ozaslan","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bsheal.2024.04.004_b0125","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","article-title":"Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals","volume":"29","author":"Lohse","year":"1999","journal-title":"Hepatol."},{"key":"10.1016\/j.bsheal.2024.04.004_b0130","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/lt.25756","article-title":"Coronaviruses and immunosuppressed patients: the facts during the third epidemic","volume":"26","author":"D\u2019Antiga","year":"2020","journal-title":"Liver. Transpl."},{"key":"10.1016\/j.bsheal.2024.04.004_b0135","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"}],"container-title":["Biosafety and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590053624000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590053624000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T16:49:39Z","timestamp":1719074979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590053624000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2590053624000545"],"URL":"https:\/\/doi.org\/10.1016\/j.bsheal.2024.04.004","relation":{},"ISSN":["2590-0536"],"issn-type":[{"value":"2590-0536","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of ursodeoxycholic acid therapy in autoimmune liver disease patients with COVID-19 and its clinical prognosis","name":"articletitle","label":"Article Title"},{"value":"Biosafety and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bsheal.2024.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Chinese Medical Association Publishing House. Published by Elsevier BV.","name":"copyright","label":"Copyright"}]}}